ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study
Gabriel Boeru,1 Ivan Milanov,2 Francesca De Robertis,3 Wojciech Kozubski,4 Michael Lang,5 Sònia Rojas-Farreras,6 Mark Tomlinson7 1Military Hospital, Bucharest, Romania; 2University Hospital Saint Naum, Sofia, Bulgaria; 3Department of Neurology, Vito Fazzi Hospital of Lecce, Lecce, Italy;...
Guardado en:
Autores principales: | Boeru G, Milanov I, De Robertis F, Kozubski W, Lang M, Rojas-Farreras S, Tomlinson M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/999807382c6d45288a4c359c5b7c0c33 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance
por: Berteau C, et al.
Publicado: (2015) -
Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
por: VanDevanter DR, et al.
Publicado: (2011) -
Updates on the use of ureteral stents: focus on the Resonance® stent
por: Thomas MT Turk, et al.
Publicado: (2010) -
The VariLift® Interbody Fusion System: expandable, standalone interbody fusion
por: Emstad E, et al.
Publicado: (2015) -
Evaluation of the angled Episcissors-60® episiotomy scissors in spontaneous vaginal deliveries
por: Patel RP, et al.
Publicado: (2014)